UA99211C2 - Nanocapsules with functions of nanorobot - Google Patents
Nanocapsules with functions of nanorobotInfo
- Publication number
- UA99211C2 UA99211C2 UAA201104513A UAA201104513A UA99211C2 UA 99211 C2 UA99211 C2 UA 99211C2 UA A201104513 A UAA201104513 A UA A201104513A UA A201104513 A UAA201104513 A UA A201104513A UA 99211 C2 UA99211 C2 UA 99211C2
- Authority
- UA
- Ukraine
- Prior art keywords
- nanorobot
- nanocapsules
- functions
- hydroxoapatite
- biology
- Prior art date
Links
- 239000002088 nanocapsule Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to nanocapsules with functions of nanorobot and can be used in medicine and biology for the early detection and therapy of cancer at cell level. The nanocapsule comprises magnetite, hydroxoapatite as modifying agent, cytotoxic preparation and conjugated monoclonal antibody.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201104513A UA99211C2 (en) | 2011-04-13 | 2011-04-13 | Nanocapsules with functions of nanorobot |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201104513A UA99211C2 (en) | 2011-04-13 | 2011-04-13 | Nanocapsules with functions of nanorobot |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99211C2 true UA99211C2 (en) | 2012-07-25 |
Family
ID=50848635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201104513A UA99211C2 (en) | 2011-04-13 | 2011-04-13 | Nanocapsules with functions of nanorobot |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA99211C2 (en) |
-
2011
- 2011-04-13 UA UAA201104513A patent/UA99211C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501039B1 (en) | Cytotoxic peptides and antibody drug conjugates thereof | |
| CA3019531A1 (en) | Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer | |
| TN2015000050A1 (en) | Methods of treating a tauopathy | |
| TN2015000396A1 (en) | Antibody drug conjugates | |
| NZ631197A (en) | Anti sez6 antibodies and methods of use | |
| PH12012502231A1 (en) | Anti-human trop-2 antibody having antitumor activity in vivo | |
| MX362720B (en) | ANTI-TROP-2 HUMAN ANTI-BODY THAT HAS AN IN VIVO ANTITUMORAL ACTIVITY. | |
| NZ731633A (en) | Antibodies against cd73 and uses thereof | |
| IN2014DN09098A (en) | ||
| WO2014163714A3 (en) | Antibody drug conjugates | |
| NZ628314A (en) | Cd47 antibodies and methods of use thereof | |
| WO2013114367A8 (en) | C10rf32 antibodies, and uses thereof for treatment of cancer | |
| AU2012335543A8 (en) | HER3 antibodies and uses thereof | |
| UA112288C2 (en) | Antibody forvulation and therapeutic regimens | |
| NZ704718A (en) | Epcam aptamer for detection of cancer stem cells | |
| MX2019015604A (en) | Methods of treating a tauopathy. | |
| ZA201504538B (en) | Anti-lamp1 antibodies and antibody drug conjugates ,and uses thereof | |
| PH12013502663A1 (en) | Dosage administration of anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers | |
| EA201992513A1 (en) | BREAST CANCER TREATMENT METHOD | |
| WO2015023694A3 (en) | Method for enhancing tumor growth | |
| IL227687B (en) | Anti-alpha-v integrin antibody for use in the treatment of prostate cancer | |
| PH12013500432A1 (en) | Anti-vegfr-3 antibody compositions | |
| UY34154A (en) | DOSAGE AND ADMINISTRATION OF ANTI-ERBB3 ANTIBODIES IN COMBINATION WITH PACLITAXEL. | |
| WO2012106473A3 (en) | Dosing for treatment with anti-egfl7 antibodies | |
| AU2013342779A8 (en) | Anti-ADAM28 antibody for treating cancer |